Sfoglia per AUTORE
GERMING U
Collezione AOU Alessandria

  

Items : 3

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. in The Lancet. Haematology / Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.
2024
AOU Alessandria

Komrokji RS; Lanino L; Ball S; Bewersdorf JP; Marchetti M; Maggioni G; Travaglino E; Al Ali NH; Fenaux P; Platzbecker U; Santini V; Diez-Campelo M; Singh A; Jain AG; Aguirre LE; Tinsley-Vance SM; Schwabkey ZI; Chan O; Xie Z; Brunner AM; Kuykendall AT; Bennett JM; Buckstein R; Bejar R; Carraway HE; DeZern AE; Griffiths EA; Halene S; Hasserjian RP; et alii...

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Latagliata R; Zini G; D'Errigo MG; Bova I; Delfino IM; Arcadi MT; Cufari P; Rizzo L; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Liberati AM; Impera S; Di Renzo N; Palumbo GA; Fenaux P; Ricco A; Germing U; Molteni A; Bocchia M; Beltrami G; Castelli A; Fattizzo B; Iannì G; Russo E; Guarini A; Tripepi G; Ferrero D; et alii...

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes. in The New England journal of medicine / N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892.
2020
AOU Alessandria

Fenaux P; Platzbecker U; Mufti GJ; Garcia-Manero G; Buckstein R; Santini V; Díez-Campelo M; Finelli C; Cazzola M; Ilhan O; Sekeres MA; Falantes JF; Arrizabalaga B; Salvi F; Giai V; Vyas P; Bowen D; Selleslag D; DeZern AE; Jurcic JG; Germing U; Götze KS; Quesnel B; Beyne-Rauzy O; Cluzeau T; Voso MT; Mazure D; Vellenga E; Greenberg PL; et alii...